Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Star Combo Pharma Ltd. ( (AU:S66) ) has provided an update.
Star Combo Pharma Ltd has announced that its annual General Meeting will be held on November 25, 2025. The company has set October 19, 2025, as the deadline for director nominations. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and elect new directors, potentially impacting its future operations and market positioning.
The most recent analyst rating on (AU:S66) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Star Combo Pharma Ltd. stock, see the AU:S66 Stock Forecast page.
More about Star Combo Pharma Ltd.
Star Combo Pharma Ltd is a Sydney-based contract manufacturer specializing in vitamins, health, and beauty products. The company offers a portfolio of its own brands and has significant distribution capabilities, supplying the Australian pharmacy network and wholesale customers in Australia, Vietnam, and China. Star Combo is committed to using natural ingredients backed by scientific research and adheres to high manufacturing standards set by the Therapeutic Goods Administration.
Average Trading Volume: 29,737
Technical Sentiment Signal: Buy
Current Market Cap: A$31.73M
See more insights into S66 stock on TipRanks’ Stock Analysis page.